What are the clinical signs of atropinisation (anticholinergic toxicity)?

Signs of Atropinisation (Anticholinergic Toxicity)

Atropinisation presents with a classic constellation of peripheral and central anticholinergic signs that can be remembered by the mnemonic: "hot as a hare, red as a beet, dry as a bone, blind as a bat, and mad as a hatter." 1

Peripheral Anticholinergic Signs

Cardiovascular Effects

• Tachycardia is the hallmark cardiac manifestation, with heart rates often exceeding normal limits 2, 3
• Mild hypertension or blood pressure fluctuations (≥20 mm Hg diastolic or ≥25 mm Hg systolic change within 24 hours) may occur 2
• Palpitations are common with excessive dosing 4

Dermatologic Manifestations

• Hot, dry, flushed, erythematous skin with complete absence of sweating is pathognomonic 2, 3
• The skin is characteristically warm to touch, distinguishing it from sympathomimetic toxicity which presents with diaphoresis 3
• "Atropine flush" may be visible, particularly in the blush area 4

Ocular Signs

• Mydriasis (markedly dilated pupils) that are sluggish or completely fixed to light 2, 3
• Blurred vision and difficulty with accommodation 4
• These pupillary findings are among the most reliable diagnostic features 2

Gastrointestinal Effects

• Hypoactive or absent bowel sounds on auscultation 2, 3
• Dry mouth and difficulty swallowing 4
• Decreased gastrointestinal motility 5

Urinary Symptoms

• Urinary retention requiring potential catheterization 2
• Urinary hesitancy may precede frank retention 5

Respiratory Changes

• Tachypnea (rapid breathing rate) 2, 3
• Reduced pharyngeal and bronchial secretions 2

Central Nervous System Effects

Mental Status Alterations

• Agitated delirium is the most common central manifestation 2, 1
• Restlessness, confusion, and disorientation 4, 6
• Hallucinations and incomprehensible speech 2
• Progression from mild confusion to frank delirium or coma in severe cases 2, 5

Neuromuscular Signs

• Tremor, ataxia, and fatigue 4
• Dizziness and restlessness 4

Severe Toxicity Indicators

• Hyperthermia (temperature elevation up to 38.8°C or higher) due to inability to sweat 2, 4
• Seizures may occur with toxic doses 4
• Coma, respiratory depression, and circulatory collapse indicate life-threatening intoxication 4

Dose-Related Progression

The severity of atropinisation correlates with dose exposure. 4 Mild toxicity presents with tachycardia, dry mouth, and mydriasis, while moderate toxicity adds delirium and hyperthermia. Severe intoxication manifests with coma, seizures, and potential respiratory failure requiring aggressive intervention. 4

Critical Diagnostic Considerations

The combination of dry, flushed skin with mydriasis and absent bowel sounds in the presence of tachycardia and altered mental status should immediately suggest anticholinergic toxicity. 2, 3 The absence of sweating despite fever is particularly distinctive and helps differentiate this syndrome from other causes of altered mental status. 3

Common Pitfalls

• Overlooking topical atropine (ophthalmic drops) as a source of systemic toxicity, especially in children and adolescents 7
• Mistaking mild anticholinergic effects for normal aging in elderly patients, who are particularly susceptible 5
• Failing to recognize that even therapeutic doses of ophthalmic atropine can cause systemic absorption and full anticholinergic syndrome 7
• Underestimating the severity based on initial presentation, as symptoms can rapidly progress 2

Pediatric Considerations

Children may be more susceptible to anticholinergic effects and can develop severe toxicity at lower doses. 4 In pediatric populations, 10 mg or less of atropine may be fatal, and "atropine fever" due to suppressed sweat gland activity is more common in infants and small children. 4